Check out the companies making headlines in premarket trading: Sunrun — Shares fell nearly 2% following a downgrade to sector perform from outperform by RBC Capital Markets. The stock on Tuesday recorded its biggest one-day loss in its history amid a sell-off in solar names. CERo Therapeutics Holdings — Stock in the immunotherapy company pulled back about 28%. On Tuesday, the U.S. Food and Drug Administration gave the company’s acute myeloid leukemia drug CER-1236 an orphan drug designation . Shares rose more than 188% on that news. Chemours — The chemical stock dropped about 1% after an updated second-quarter forecast showed weakness in a key profit metric. Chemours said it expects consolidated adjusted EBITDA, or earnings before interest, taxes, depreciation and amortization, of $215 million to $225 million for the period. Wall Street expectations called for $236 million, according to FactSet. Regencell Bioscience — Shares dropped 13% after an eye-watering move higher this week . The Hong Kong-based developer of traditional Chinese herbal treatments has said it can treat childhood ADHD and autism. Regencell jumped 30% on Tuesday and soared 283% Monday, following a 38-for-1 stock split. It has gained more than 59,000% this year. Oracle — The software company gained more than 1% after Guggenheim raised its price target on the stock to the highest on the Street. Analyst John DiFucci said Oracle is “on the precipice of a narrative shift that has been decades of technology innovation in the making.” Zoetis — Shares of the animal health company slipped 1% following a downgrade at Stifel to hold from buy. The firm said it expects Zoetis’ revenue growth to decelerate further amid increasing competition. Korn Ferry — Shares of the consulting firm gained about 10% after fourth-quarter results surpassed analysts’ estimates on the top and bottom lines. Korn Ferry earned $1.32 per share, excluding items, on revenue of $712 million. Analysts polled by FactSet expected a profit of $1.26 per share and revenue of $689.9 million. Circle Internet Group — Stock in the company behind stablecoin USDC advanced 3%, after the U.S. Senate passed the GENIUS bill . The legislation is the first of its kind and establishes federal guidelines for digital dollars that are pegged to the greenback. — CNBC’s Sarah Min, Michelle Fox, Alex Harring, Fred Imbert and Jesse Pound contributed reporting.
Add A Comment
About Us
Our finance blog is your go-to resource for expert financial advice, covering everything from personal budgeting and saving strategies to smart investing and market analysis. Stay updated with the latest trends, tips, and insights to help you make informed decisions and achieve financial success.
Popular Post
© 2025 Budgetsmart.ai – All rights reserved.